Although the American College of Cardiology and the European Society of Cardiology now advise people with ICDs not to participate in vigorous sports, a new study offers strong support for people with ICDs who want to take part in sports. Now findings from the ICD Sports Safety Registry, published in Circulation, provide vital new information about this important…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

This is why we hold conferences — to share in the value of research and to promote enthusiasm to continue with new endeavors.

The majority of patients who receive an ICD for primary prevention without a pacing indication have a dual-chamber ICD implanted. Although there are a number of theoretical advantages with dual-chamber devices, they are more likely to cause complications than single-chamber devices. Although CMS requires providers to justify the medical necessity of dual-chamber devices, current guidelines…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

First results in human patients of a novel leadless pacemaker were presented last week at the HRS meeting in Denver by Vivek Reddy.  Pacemaker leads are the most common source of complications associated with pacemakers today. The self-contained device is delivered via catheter to the right ventricle, to which it is attached with a fixation mechanism.  The device…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Looking back at the knowledge gained and friendships kindled at HRS 2013, this Fellow looks forward to HRS 2014.

I finally managed to walk to the Fellows in Training lounge, hoping to connect with some co-fellows. I did find lot of fellows, but to my surprise Dr. Zipes was there and ready to answer burning questions about getting published.

In recent weeks the cardiac resynchronization therapy (CRT) field has been absorbing the publication of the BLOCK HF trial in the New England Journal of Medicine and the publication of the NARROW-CRT trial in Circulation: Arrhythmia and Electrophysiology. These trials raised the possibility that CRT may improve clinical status in some patients with ischemic cardiomyopathy…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

HRS yields useful insights, both personal and professional.

Encouraging long-term results from the PROTECT AF trial comparing the Watchman left atrial appendage closure device to warfarin in atrial fibrillation (AF) patients were presented yesterday at the Heart Rhythm Society meeting in Denver. Previously the main results of the trial, published in the Lancet, demonstrated that the Watchman was noninferior to warfarin, but the total number of…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

An emotion-raising debate, a late-breaker session, and technological innovations focus this fellow, despite Denver’s many attractions.